» Articles » PMID: 23377197

NK Cells Dysfunction in Systemic Lupus Erythematosus: Relation to Disease Activity

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2013 Feb 5
PMID 23377197
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Through their cytotoxic capacities and cytokine production, natural killer (NK) cells modulate autoimmune diseases. However, their role in the pathogenesis of systemic lupus erythematosus (SLE) has not been extensively studied. The aim of this study was to analyse the immunophenotypic and functional characteristics of the two major NK cell subsets in SLE and relate them with disease activity. Peripheral blood samples from 44 patients with active (n = 18) and inactive SLE (n = 26) and 30 controls were analysed by flow cytometry to evaluate NK cell subsets, according to: the differential expression of CXCR3 and CD57; expression of granzyme B and perforin; and production of interferon gamma (IFN-γ) and tumor necrosis alpha (TNF-α), after PMA/ionomycin activation. A clear decrease in absolute and relative numbers of circulating NK cells was found in SLE, particularly in active disease, while the proportions of the major NK cell subsets were unaffected. Active SLE was associated with a reduced CXCR3 expression on both NK cell subsets and a lower frequency of CD56(dim) NK cells expressing CXCR3. Furthermore, granzyme B expression was decreased in both SLE groups, but the percentage of NK cells expressing granzyme B and perforin was higher, particularly in active disease. We found a significant decrease in the percentage of CD56(bright) and CD56(dim) NK cells producing TNF-α and of its expression on CD56(dim) NK cells in active disease, while IFN-γ expression on CD56(bright) NK cells was increased in both SLE groups. Our findings suggest that NK cell subsets exhibit unique phenotypic and functional changes that are particularly evident in active SLE, and they may have the potential to affect the disease outcome.

Citing Articles

Changes of Peripheral T Cells in Systemic Lupus Erythematosus Patients.

Lao J, Huang R, Wu R, Yuan Y Immun Inflamm Dis. 2025; 13(2):e70156.

PMID: 39981706 PMC: 11843224. DOI: 10.1002/iid3.70156.


Immune complex deposition promotes NK cell accumulation in the kidney.

De la Cruz A, Garces M, Larios E, Madera-Salcedo I, Crispin J, Rosetti F PLoS One. 2024; 19(11):e0312141.

PMID: 39570975 PMC: 11581347. DOI: 10.1371/journal.pone.0312141.


Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.

Chen S, Zhu H, Jounaidi Y Signal Transduct Target Ther. 2024; 9(1):302.

PMID: 39511139 PMC: 11544004. DOI: 10.1038/s41392-024-02005-w.


Decreased Peripheral Blood Natural Killer Cell Count in Untreated Juvenile Dermatomyositis Is Associated with Muscle Weakness.

Khojah A, Pachman L, Bukhari A, Trinh C, Morgan G, Pandey S Int J Mol Sci. 2024; 25(13.

PMID: 39000234 PMC: 11241205. DOI: 10.3390/ijms25137126.


Active juvenile systemic lupus erythematosus is associated with distinct NK cell transcriptional and phenotypic alterations.

Radziszewska A, Peckham H, de Gruijter N, Restuadi R, Wu W, Jury E Sci Rep. 2024; 14(1):13074.

PMID: 38844784 PMC: 11156641. DOI: 10.1038/s41598-024-62325-3.


References
1.
Huang Z, Fu B, Zheng S, Li X, Sun R, Tian Z . Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus. J Immunol. 2011; 186(6):3421-31. PMC: 3097030. DOI: 10.4049/jimmunol.1000569. View

2.
Lanier L, Le A, Phillips J, Warner N, Babcock G . Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983; 131(4):1789-96. View

3.
Henriques A, Ines L, Couto M, Pedreiro S, Santos C, Magalhaes M . Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus. Cell Immunol. 2010; 264(1):97-103. DOI: 10.1016/j.cellimm.2010.05.004. View

4.
Avramescu C, Biciusca V, Daianu T, Turculeanu A, Balasoiu M, Popescu S . Cytokine panel and histopathological aspects in the systemic lupus erythematosus. Rom J Morphol Embryol. 2010; 51(4):633-40. View

5.
Green M, Kennell A, Larche M, Seifert M, Isenberg D, Salaman M . Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol. 2005; 141(1):165-73. PMC: 1809425. DOI: 10.1111/j.1365-2249.2005.02822.x. View